Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
5/10
|
32.65 | 85.34 | -61.74% | 40.52 | -19.42% |
| P/S |
|
10.35 | 9.92 | 4.3% |
|
|
| P/BV |
|
9.51 | 5.45 | 74.41% |
|
|
| P/FCF |
|
0 | 0 | 0% |
|
|
| Ev/Ebitda |
|
26.72 | 47.72 | -44% |
|
|
| Ev/S |
|
9.62 | 9.78 | -1.61% |
|
|
| Ev/FCF |
|
0 | 0 | 0% |
|
|
| E/P |
|
0.0306 | 0.0139 | 120.84% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
9/10
|
34.39 | 5.33 | 545.06% | 36.79 | -6.53% |
| ROE |
|
32.13 | 7.39 | 334.76% |
|
|
| ROA |
|
15.73 | 2.77 | 468.54% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
31.68 | 6.46 | 390.16% |
|
|
| ROCE |
|
0 | 0 | 0% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
0.0205 | 2.52 | -99.19% | 0.0205 | +0% |
| Nеt Debt/Ebitda |
|
0 | 0 | 0% |
|
|
| Debt/Ratio |
|
0 | 0 | 0% |
|
|
| Debt/Equity |
|
0 | 0 | 0% |
|
|
| Debt/Net Income |
|
0.0238 | -0.6871 | -103.47% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
4.13/10
|
1.65 | 0.8249 | 100.03% | 1.17 | +40.77% |
| Number of years of dividend growth |
|
5 | 1.03 | 387.5% | ||
| DSI |
|
0.9167 | 0.889 | 3.11% |
|
|
| Average dividend growth |
|
40.53 | 2.1 | 1829.28% |
|
|
| Average percentage for 5 years |
|
1.17 | 0.6336 | 84.99% |
|
|
| Average percentage for payments |
|
118.04 | 27.98 | 321.82% |
|
|
| Difference from average difference in sector |
|
0.8251 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
110.99 | 61.1 | 81.65% | ||
| Growth impulse Ebitda in 5 years |
|
156.91 | 15.78 | 894.36% | ||
| Growth impulse Net Income in 5 years |
|
147.45 | 36.32 | 305.97% | ||
| Growth impulse FCF in 5 years |
|
112.26 | 136.26 | -17.61% | ||
| Growth impulse EPS in 5 years |
|
486.5 | 79.32 | 513.34% |
IP Score
7.63/10
